An Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
An Zhao has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Michael A. Partridge
Regeneron Pharmaceuticals Inc., Tarrytown, USA
2 shared publications - Bonnie Wu
Johnson & Johnson Innovative Medicine, Spring House, PA, USA
1 shared publication - Boris Gorovits
Sana Biotechnology, Cambridge, USA
1 shared publication - Brian Long
BioMarin Pharmaceutical Inc., Novato, CA, USA
1 shared publication - Ching-Ha Lai
Regeneron Pharmaceuticals Inc., Tarrytown, USA
1 shared publication - Christian Vettermann
D Molecular Therapeutics, Emeryville, USA
1 shared publication
Latest Publications
- Open Access
- 19 May 2026
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (4) , 106
Immunogenicity Assessment for siRNA Therapeutics: A Risk-Based Proposal for Event-Driven Testing
Oligonucleotide therapeutics (ONTs) have emerged as a transformative treatment modality with numerous products approved globally for addressing a variety o
- 19 May 2026
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (4) , 106
Open AccessImmunogenicity Assessment for siRNA Therapeutics: A Risk-Based Proposal for Event-Driven Testing
Oligonucleotide therapeutics (ONTs) have emerged as a transformative treatment modality with numerous products approved globally for addressing a variety o
- 5 January 2026
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (1) , 43
Assessment of Immune Responses Against AAV Encoded Transgene Products
The number of clinical investigations and approved applications of adeno-associated virus (AAV) based transgene product (TP) delivery has grown steadily. T
- 5 January 2026
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (1) , 43
Assessment of Immune Responses Against AAV Encoded Transgene Products
The number of clinical investigations and approved applications of adeno-associated virus (AAV) based transgene product (TP) delivery has grown steadily. T